Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
45.1M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
37.9M
-
Shares change
-
+41K
-
Total reported value, excl. options
-
$416M
-
Value change
-
+$11.3M
-
Number of buys
-
37
-
Number of sells
-
-21
-
Price
-
$10.97
Significant Holders of Third Harmonic Bio, Inc. - Common Stock, par value $0.0001 per share (THRD) as of Q4 2023
68 filings reported holding THRD - Third Harmonic Bio, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Third Harmonic Bio, Inc. - Common Stock, par value $0.0001 per share (THRD) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.9M shares
of 45.1M outstanding shares and own 84.13% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (10.9M shares), ORBIMED ADVISORS LLC (5.78M shares), BVF INC/IL (4.37M shares), EcoR1 Capital, LLC (3.18M shares), GENERAL ATLANTIC, L.P. (2.96M shares), RA CAPITAL MANAGEMENT, L.P. (2.03M shares), BlackRock Inc. (1.39M shares), BRAIDWELL LP (1.32M shares), JPMORGAN CHASE & CO (1.01M shares), and VANGUARD GROUP INC (840K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.